Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1Phase 1 1

Status

Completed 6

Sponsor Class

INDUSTRY 11OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6Thoracic 3Breast 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 3Carcinoma, Transitional Cell 3Urethral Neoplasms 2Ureteral Neoplasms 2Prostatic Neoplasms 1Penile Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Carcinoma 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × vinflunine × Genitourinary × Clear all
NCT00545766 2021-12-16

Vinflunine in Hormone Refractory Prostate Cancer (HRPC)

SCRI Development Innovations, LLC

Phase 2 Completed
41 enrolled 11 charts
Genitourinary

Prostatic Neoplasms

NCT02057913 2020-07-23

VinCaP

Institute of Cancer Research, United Kingdom

Phase 2 Completed
22 enrolled
Genitourinary

Penile Neoplasms

NCT02665039 2019-10-08

VINGEM

Karolinska University Hospital

Phase 2 Completed
62 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT01844947 2019-04-26

VINSOR

Karolinska University Hospital

Phase 1 Completed
22 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

NCT01529411 2019-04-04

MAJA

Spanish Oncology Genito-Urinary Group

Phase 2 Completed
86 enrolled
Genitourinary

Carcinoma, Carcinoma, Transitional Cell, Neoplasm Metastasis, Neoplasms

NCT01265940 2012-10-10

Pazopanib and Vinflunine in Urothelial Cancer of the Bladder

Lukas-Krankenhaus GmbH

Phase 1/2 Completed
5 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡